AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿ“ฐ Latest breakthroughs
๐Ÿ—บ๏ธ Disease Atlas ยท Measurement

Parkinson's disease symptom measurement

Quantification of some aspect of Parkinson's disease symptoms such as their frequency, severity or ratio.

๐Ÿ”” Follow weekly
๐Ÿงฌ5genes / proteins with evidence
๐Ÿ’Š0drugs and clinical candidates
๐Ÿงช1recruiting trials worldwide
๐Ÿง 

Understand Parkinson's disease symptom measurement

Brain and nerves ยท Nerve cells that slowly stop working
๐ŸŽ“ Learn more

What it is

Quantification of some aspect of Parkinson's disease symptoms such as their frequency, severity or ratio.

From the Open Targets disease record โ†—

๐Ÿง  Brain and nerves: In neurodegenerative diseases, nerve cells in the brain or spinal cord stop working and die over time - affecting memory (Alzheimer's disease), movement (Parkinson's disease) or muscles (ALS).

โ“ Why it happens

  • Proteins fold the wrong way and clump together inside or between nerve cells - amyloid and tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease.
  • Inflammation, some genes (such as APOE4) and, above all, age raise the risk.

๐Ÿซ€ What it does to the body

  • As connections between nerve cells are lost, memory, thinking, movement or speech fade.
  • The changes start years - often decades - before the first symptoms.

๐Ÿงฑ Why it is hard to cure

  • Most medicines cannot easily pass the blood-brain barrier that protects the brain.
  • By the time symptoms appear, many nerve cells are already lost, and they do not grow back.
  • Many drug trials have failed, partly because the diseases are found late.

๐Ÿš€ What research is trying now

  • Antibodies that clear amyloid and modestly slow early Alzheimer's disease (approved in some countries).
  • Blood tests that detect Alzheimer's changes years earlier.
  • Gene-targeted medicines, such as one approved in the US for an inherited form of ALS.

General information about brain and nerves, reviewed by people; it does not describe any one person. Below: the evidence for Parkinson's disease symptom measurement itself.

๐Ÿค–

AI briefing

Where the science on Parkinson's disease symptom measurement stands, from the evidence on this page

AI reads the targets, drugs, trials and papers below and writes where the science stands โ€” every claim cited. It is shared with everyone who opens Parkinson's disease symptom measurement.

๐ŸŽฏ

Top targets

Genes and proteins ranked by Open Targets evidence (0-1)
RAB44 RAB44, member RAS oncogene familyantibody๐ŸงŠ AlphaFold structure โ†— 0.24
TSHZ1 teashirt zinc finger homeobox 1PROTAC๐ŸงŠ AlphaFold structure โ†— 0.18
LIPC lipase C, hepatic typePROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.15
PTGR3 prostaglandin reductase 3PROTACsmall molecule๐ŸงŠ AlphaFold structure โ†— 0.12
ZNF407 zinc finger protein 407PROTACantibody๐ŸงŠ AlphaFold structure โ†— 0.02

Green labels: what the target is known to be druggable by. The score combines genetics, somatic mutations, drugs, expression and literature.

๐Ÿ’Š

Drugs and candidates

Every medicine linked to Parkinson's disease symptom measurement, by how far it has got

No drugs recorded yet.

๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy